Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$531M |
| 2 |
Microsoft
MSFT
|
+$400M |
| 3 |
JPMorgan Chase
JPM
|
+$375M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$351M |
| 5 |
Amazon
AMZN
|
+$346M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.22B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$396M |
| 3 |
SPDR S&P Bank ETF
KBE
|
+$294M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$249M |
| 5 |
SPDR S&P Biotech ETF
XBI
|
+$247M |
Sector Composition
| 1 | Financials | 12.99% |
| 2 | Technology | 11.64% |
| 3 | Energy | 9.09% |
| 4 | Consumer Discretionary | 8.31% |
| 5 | Healthcare | 8.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NTUS
2201
DELISTED
Natus Medical Inc
NTUS
| $4.62M | ﹤0.01% |
132,632
+42,015
| +46% | +$1.46M |
|
|
PNK
2202
DELISTED
Pinnacle Entertainment Inc.
PNK
| $4.6M | ﹤0.01% |
317,537
-167,725
| -35% | -$2.43M |
|
2203
Xencor
XNCR
$615M
| $4.6M | ﹤0.01% |
174,840
+36,051
| +26% | +$949K |
|
|
SIR
2204
DELISTED
SELECT INCOME REIT
SIR
| $4.59M | ﹤0.01% |
414,096
-679,419
| -62% | -$7.53M |
|
|
IPXL
2205
DELISTED
Impax Laboratories, Inc.
IPXL
| $4.58M | ﹤0.01% |
345,777
+145,500
| +73% | +$1.93M |
|
|
ANH
2206
DELISTED
Anworth Mortgage Asset Corporation
ANH
| $4.57M | ﹤0.01% |
883,030
+3,639
| +0.4% | +$18.8K |
|
2207
Chemed
CHE
$6.52B
| $4.55M | ﹤0.01% |
28,384
-45,644
| -62% | -$7.32M |
|
2208
First Trust NYSE Arca Biotechnology Index Fund
FBT
$1.08B
| $4.55M | ﹤0.01% |
50,038
+38
| +0.1% | +$3.45K |
|
2209
Installed Building Products
IBP
$7.15B
| $4.53M | ﹤0.01% |
109,683
-36,771
| -25% | -$1.52M |
|
2210
iShares MSCI Kokusai Fund
TOK
$234M
| $4.52M | ﹤0.01% |
83,168
+39,230
| +89% | +$2.13M |
|
2211
Select Medical
SEM
$1.5B
| $4.51M | ﹤0.01% |
631,884
+448,446
| +244% | +$3.2M |
|
2212
PotlatchDeltic
PCH
$3.13B
| $4.5M | ﹤0.01% |
108,099
-724
| -0.7% | -$30.2K |
|
|
LUX
2213
DELISTED
Luxottica Group
LUX
| $4.5M | ﹤0.01% |
83,791
+44,110
| +111% | +$2.37M |
|
|
FPRX
2214
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $4.5M | ﹤0.01% |
89,769
-564,583
| -86% | -$28.3M |
|
2215
Invesco Solar ETF
TAN
$741M
| $4.49M | ﹤0.01% |
271,029
+895
| +0.3% | +$14.8K |
|
|
ARCH
2216
DELISTED
Arch Resources, Inc.
ARCH
| $4.47M | ﹤0.01% |
+57,252
| New | +$4.47M |
|
2217
BGC Group
BGC
$4.63B
| $4.46M | ﹤0.01% |
678,025
+37,091
| +6% | +$244K |
|
2218
SPX Corp
SPXC
$9.18B
| $4.43M | ﹤0.01% |
186,755
+63,460
| +51% | +$1.5M |
|
2219
Invesco S&P 500 Equal Weight Consumer Discretionary ETF
RSPD
$223M
| $4.43M | ﹤0.01% |
150,333
+333
| +0.2% | +$9.8K |
|
2220
FibroGen
FGEN
$46.5M
| $4.42M | ﹤0.01% |
8,267
+2,695
| +48% | +$1.44M |
|
2221
Gannett
GCI
$642M
| $4.42M | ﹤0.01% |
276,446
+139,207
| +101% | +$2.23M |
|
2222
Twilio
TWLO
$15.7B
| $4.42M | ﹤0.01% |
153,185
+131,285
| +599% | +$3.79M |
|
|
FTD
2223
DELISTED
FTD Companies, Inc. Common Stock
FTD
| $4.41M | ﹤0.01% |
185,142
+10,239
| +6% | +$244K |
|
2224
Orthofix Medical
OFIX
$586M
| $4.4M | ﹤0.01% |
121,542
-37,523
| -24% | -$1.36M |
|
|
FTRPR
2225
DELISTED
Frontier Communications Corporation 11.125% Series A Mandatory Convertible Preferred Stock
FTRPR
| $4.39M | ﹤0.01% |
+61,694
| New | +$4.39M |
|